NASDAQ:EXAS

Exact Sciences News Headlines

$125.54
-2.96 (-2.30 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$123.50
Now: $125.54
$128.50
50-Day Range
$116.57
MA: $131.34
$147.81
52-Week Range
$63.32
Now: $125.54
$159.54
Volume1.22 million shs
Average Volume1.79 million shs
Market Capitalization$21.23 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.64

Headlines

Exact Sciences (NASDAQ EXAS) News Headlines Today

SourceHeadline
Exact Sciences (NASDAQ:EXAS) Rating Lowered to Strong Sell at Zacks Investment ResearchExact Sciences (NASDAQ:EXAS) Rating Lowered to Strong Sell at Zacks Investment Research
marketbeat.com - March 16 at 9:45 AM
Is EXACT Sciences (EXAS) Stock A Buy or Sell?Is EXACT Sciences (EXAS) Stock A Buy or Sell?
finance.yahoo.com - March 29 at 12:31 PM
Exact Sciences Co. (NASDAQ:EXAS) Given Consensus Rating of "Buy" by AnalystsExact Sciences Co. (NASDAQ:EXAS) Given Consensus Rating of "Buy" by Analysts
americanbankingnews.com - March 29 at 11:02 AM
The Rockefeller Foundation teams up with testing companies to aid school reopeningsThe Rockefeller Foundation teams up with testing companies to aid school reopenings
finance.yahoo.com - March 26 at 1:09 PM
Is It Too Late to Buy EXACT Sciences (EXAS) Stock?Is It Too Late to Buy EXACT Sciences (EXAS) Stock?
finance.yahoo.com - March 23 at 5:49 PM
First Week of EXAS May 21st Options TradingFirst Week of EXAS May 21st Options Trading
nasdaq.com - March 19 at 1:46 PM
Why Is Exact Sciences (EXAS) Down 8.9% Since Last Earnings Report?Why Is Exact Sciences (EXAS) Down 8.9% Since Last Earnings Report?
finance.yahoo.com - March 18 at 3:04 PM
Exact Sciences Has 2 Strategies - Bullish Fundamentals but Bearish ChartsExact Sciences Has 2 Strategies - Bullish Fundamentals but Bearish Charts
finance.yahoo.com - March 16 at 2:54 PM
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility CollaborationNeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
finance.yahoo.com - March 9 at 9:40 AM
TFF Pharmaceuticals Provides Update on Clinical Development ProgramsTFF Pharmaceuticals Provides Update on Clinical Development Programs
finance.yahoo.com - March 4 at 9:29 AM
Exact Sciences Corporation Rings the Closing BellExact Sciences Corporation Rings the Closing Bell
nasdaq.com - February 24 at 1:03 PM
Adding $5,000 to These 2 Top Stocks Could Make You Richer in 2021 (and Beyond)Adding $5,000 to These 2 Top Stocks Could Make You Richer in 2021 (and Beyond)
finance.yahoo.com - February 21 at 8:21 AM
Exact Sciences Corporations (EXAS) CEO Kevin Conroy on Q4 2020 Results - Earnings Call TranscriptExact Sciences Corporation's (EXAS) CEO Kevin Conroy on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 18 at 8:42 PM
Why Exact Sciences Stocks Is Trading Lower TodayWhy Exact Sciences Stocks Is Trading Lower Today
benzinga.com - February 17 at 10:35 PM
Exact Sciences acquires Arizona startup to boost oncology businessExact Sciences acquires Arizona startup to boost oncology business
bizjournals.com - February 17 at 5:34 PM
Exact Sciences (EXAS) Q4 Earnings, Revenues Top EstimatesExact Sciences (EXAS) Q4 Earnings, Revenues Top Estimates
msn.com - February 17 at 12:34 PM
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply DealThe Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
finance.yahoo.com - February 17 at 12:34 PM
Exact Sciences Announces Fourth Quarter 2020 ResultsExact Sciences Announces Fourth Quarter 2020 Results
finance.yahoo.com - February 16 at 8:14 PM
Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hopes Genomics Institute, TGenExact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hope's Genomics Institute, TGen
finance.yahoo.com - February 16 at 8:14 PM
Recap: Exact Sciences Q4 EarningsRecap: Exact Sciences Q4 Earnings
finance.yahoo.com - February 16 at 8:14 PM
EXACT Sciences Corp. to Host Earnings CallEXACT Sciences Corp. to Host Earnings Call
finance.yahoo.com - February 16 at 3:14 PM
A Preview Of Exact Sciencess EarningsA Preview Of Exact Sciences's Earnings
finance.yahoo.com - February 15 at 1:51 PM
Is a Surprise Coming for Exact Sciences (EXAS) This Earnings Season?Is a Surprise Coming for Exact Sciences (EXAS) This Earnings Season?
finance.yahoo.com - February 12 at 1:56 PM
Exact Sciences schedules fourth quarter 2020 earnings callExact Sciences schedules fourth quarter 2020 earnings call
finance.yahoo.com - February 1 at 7:36 AM
Exact Sciences to participate in February investor conferencesExact Sciences to participate in February investor conferences
finance.yahoo.com - February 1 at 7:36 AM
Apogee Enterprises, Inc. (NASDAQ:APOG) Passed Our Checks, And Its About To Pay A US$0.20 DividendApogee Enterprises, Inc. (NASDAQ:APOG) Passed Our Checks, And It's About To Pay A US$0.20 Dividend
finance.yahoo.com - January 25 at 5:16 AM
Exact Sciences (EXAS) Soars: Stock Adds 9.8% in SessionExact Sciences (EXAS) Soars: Stock Adds 9.8% in Session
finance.yahoo.com - January 12 at 12:53 PM
Stock Alert: Exact Sciences Touches New HighStock Alert: Exact Sciences Touches New High
nasdaq.com - January 11 at 11:40 AM
Exact Sciences Sees Q4 Revenue Above ViewExact Sciences Sees Q4 Revenue Above View
nasdaq.com - January 11 at 1:38 AM
Exact Sciences Announces Preliminary Fourth Quarter 2020 ResultsExact Sciences Announces Preliminary Fourth Quarter 2020 Results
finance.yahoo.com - January 10 at 8:38 PM
Exact Sciences Corporation (EXAS)Exact Sciences Corporation (EXAS)
seekingalpha.com - January 6 at 10:53 PM
EXACT Sciences Reaches Analyst Target PriceEXACT Sciences Reaches Analyst Target Price
nasdaq.com - December 25 at 12:39 AM
Is EXAS A Good Stock To Buy According To Hedge Funds?Is EXAS A Good Stock To Buy According To Hedge Funds?
finance.yahoo.com - December 22 at 7:05 PM
Earnings Beat: Apogee Enterprises, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsEarnings Beat: Apogee Enterprises, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
finance.yahoo.com - December 22 at 2:05 PM
DermTech: Stickers To Diagnose CancerDermTech: Stickers To Diagnose Cancer
seekingalpha.com - December 21 at 11:47 PM
Exact Sciences Breaks OutExact Sciences Breaks Out
finance.yahoo.com - December 21 at 6:46 PM
EXAS Jan 2021 90.000 callEXAS Jan 2021 90.000 call
finance.yahoo.com - December 17 at 11:37 PM
This IBD Stock Of The Day Hasnt Broken Out Yet — But Its Actionable NowThis IBD Stock Of The Day Hasn't Broken Out Yet — But It's Actionable Now
finance.yahoo.com - December 17 at 1:31 PM
Should I Buy Apogee Enterprises, Inc. (APOG)?Should I Buy Apogee Enterprises, Inc. (APOG)?
finance.yahoo.com - December 11 at 7:11 PM
New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical PracticeNew Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice
finance.yahoo.com - December 11 at 9:11 AM
Notable Friday Option Activity: EXAS, LB, XOMNotable Friday Option Activity: EXAS, LB, XOM
nasdaq.com - December 4 at 5:17 PM
Apogee Enterprises to Report Fiscal 2021 Third Quarter Financial ResultsApogee Enterprises to Report Fiscal 2021 Third Quarter Financial Results
finance.yahoo.com - December 3 at 8:07 AM
Exact Sciences: Stand And DeliverExact Sciences: Stand And Deliver
seekingalpha.com - November 22 at 6:13 PM
EXAS Nov 2020 134.000 putEXAS Nov 2020 134.000 put
uk.finance.yahoo.com - November 20 at 12:39 AM
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
nasdaq.com - November 19 at 7:39 PM
EXAS Nov 2020 127.000 callEXAS Nov 2020 127.000 call
uk.finance.yahoo.com - November 19 at 7:39 PM
EXAS Nov 2020 112.000 putEXAS Nov 2020 112.000 put
uk.finance.yahoo.com - November 19 at 9:37 AM
Forget Apple! Buy These 2 High-Growth Stocks InsteadForget Apple! Buy These 2 High-Growth Stocks Instead
finance.yahoo.com - November 14 at 8:42 AM
Exact Sciences Looking TightExact Sciences Looking Tight
finance.yahoo.com - November 13 at 10:42 PM
Exact Sciences Corp (EXAS) President and CEO Kevin T Conroy Sold $4 million of SharesExact Sciences Corp (EXAS) President and CEO Kevin T Conroy Sold $4 million of Shares
uk.finance.yahoo.com - November 3 at 6:04 PM
Exact Sciences (EXAS) Loses 5.6% Despite Beating Q3 EarningsExact Sciences (EXAS) Loses 5.6% Despite Beating Q3 Earnings
finance.yahoo.com - November 2 at 3:02 PM
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.